These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 33892983)

  • 21. Status of coverage of MR vaccination, after supplementary immunization activities in a rural area of South India: a rapid immunization coverage survey.
    Newtonraj A; Vincent A; Selvaraj K; Manikandan M
    Rural Remote Health; 2019 Sep; 19(3):5261. PubMed ID: 31529972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microplanning for designing vaccination campaigns in low-resource settings: A geospatial artificial intelligence-based framework.
    Augusto Hernandes Rocha T; Grapiuna de Almeida D; Shankar Kozhumam A; Cristina da Silva N; Bárbara Abreu Fonseca Thomaz E; Christine de Sousa Queiroz R; de Andrade L; Staton C; Ricardo Nickenig Vissoci J
    Vaccine; 2021 Oct; 39(42):6276-6282. PubMed ID: 34538526
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost analysis of supplemental immunization activities to deliver measles immunization to children in Anambra state, south-east Nigeria.
    Sibeudu FT; Onwujekwe OE; Okoronkwo IL
    Vaccine; 2020 Aug; 38(37):5947-5954. PubMed ID: 32651114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. From paper maps to digital maps: enhancing routine immunisation microplanning in Northern Nigeria.
    Dougherty L; Abdulkarim M; Mikailu F; Tijani U; Owolabi K; Gilroy K; Naiya A; Abdullahi A; Bodinga H; Olayinka F; Moise I
    BMJ Glob Health; 2019; 4(Suppl 5):e001606. PubMed ID: 31321093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of engaging communities in decision-making and action through traditional and religious leaders on vaccination coverage in Cross River State, Nigeria: A cluster-randomised control trial.
    Oyo-Ita A; Bosch-Capblanch X; Ross A; Oku A; Esu E; Ameh S; Oduwole O; Arikpo D; Meremikwu M
    PLoS One; 2021; 16(4):e0248236. PubMed ID: 33861742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Field challenges to measles elimination in the Democratic Republic of the Congo.
    Coulborn RM; Nackers F; Bachy C; Porten K; Vochten H; Ndele E; Van Herp M; Bibala-Faray E; Cohuet S; Panunzi I
    Vaccine; 2020 Mar; 38(13):2800-2807. PubMed ID: 32111528
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of the revised World Health Organization cluster survey methodology to classify measles-rubella vaccination campaign coverage in 47 counties in Kenya, 2016.
    Subaiya S; Tabu C; N'ganga J; Awes AA; Sergon K; Cosmas L; Styczynski A; Thuo S; Lebo E; Kaiser R; Perry R; Ademba P; Kretsinger K; Onuekwusi I; Gary H; Scobie HM
    PLoS One; 2018; 13(7):e0199786. PubMed ID: 29965975
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intervene before leaving: clustered lot quality assurance sampling to monitor vaccination coverage at health district level before the end of a yellow fever and measles vaccination campaign in Sierra Leone in 2009.
    Pezzoli L; Conteh I; Kamara W; Gacic-Dobo M; Ronveaux O; Perea WA; Lewis RF
    BMC Public Health; 2012 Jun; 12():415. PubMed ID: 22676225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sustainable Development Goals and childhood measles vaccination in Ekiti State, Nigeria: Results from spatial and interrupted time series analyses.
    Ilesanmi MM; Adeyinka DA; Olakunde BO
    Vaccine; 2022 Jun; 40(28):3861-3868. PubMed ID: 35644673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-effectiveness analysis of an intervention project engaging Traditional and Religious Leaders to improve uptake of childhood immunization in southern Nigeria.
    Oyo-Ita AE; Hanlon P; Nwankwo O; Bosch-Capblanch X; Arikpo D; Esu E; Auer C; Meremikwu M
    PLoS One; 2021; 16(9):e0257277. PubMed ID: 34529714
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measles and rubella vaccination coverage in Haiti, 2012: progress towards verifying and challenges to maintaining measles and rubella elimination.
    Tohme RA; François J; Wannemuehler K; Magloire R; Danovaro-Holliday MC; Flannery B; Cavallaro KF; Fitter DL; Purcell N; Dismer A; Tappero JW; Vertefeuille JF; Hyde TB
    Trop Med Int Health; 2014 Sep; 19(9):1105-15. PubMed ID: 25041586
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exploring data trends and providers' insights on measles immunization uptake in south-west Nigeria.
    Ilesanmi M; Olujobi B; Ilesanmi O; Umaefulam V
    Pan Afr Med J; 2023; 46():28. PubMed ID: 38107335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Potential Contribution of Supplementary Immunization Activities to Routine Immunization in Kebbi State, Nigeria.
    Omoleke SA; Getachew B; Igoh CS; Yusuf TA; Lukman SA; Loveday N
    J Prim Care Community Health; 2020; 11():2150132720932698. PubMed ID: 32508212
    [No Abstract]   [Full Text] [Related]  

  • 34. Evaluation of impact of measles rubella campaign on vaccination coverage and routine immunization services in Bangladesh.
    Uddin MJ; Adhikary G; Ali MW; Ahmed S; Shamsuzzaman M; Odell C; Hashiguchi L; Lim SS; Alam N
    BMC Infect Dis; 2016 Aug; 16():411. PubMed ID: 27519586
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiology of measles cases, vaccine effectiveness, and performance towards measles elimination in The Gambia.
    Sowe A; Njie M; Sowe D; Fofana S; Ceesay L; Camara Y; Tesfaye B; Bah S; Bah AK; Baldeh AK; Dampha BD; Baldeh SN; Touray A
    PLoS One; 2021; 16(10):e0258961. PubMed ID: 34673828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccination compliance of selected childhood immunization programs and the socio-determinant factors in Nigeria.
    Okunlola OA; Oyerinde OR; Fashina ID; Oyeyemi OT
    J Infect Dev Ctries; 2023 Oct; 17(10):1466-1473. PubMed ID: 37956381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of vaccine reminder and tracker bracelets on routine childhood immunization coverage and timeliness in urban Pakistan (2017-18): a randomized controlled trial.
    Siddiqi DA; Ali RF; Munir M; Shah MT; Khan AJ; Chandir S
    BMC Public Health; 2020 Jul; 20(1):1086. PubMed ID: 32652969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the mass measles vaccination campaign in Guangdong Province, China.
    Peng ZQ; Chen WS; He Q; Peng GW; Wu CG; Xu N; Zhao ZJ; Shu J; Tan Q; Zheng HZ; Lin LF; Deng HH; Lin JY; Zhang YH
    Int J Infect Dis; 2012 Feb; 16(2):e99-103. PubMed ID: 22119269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nationwide measles supplementary immunization activities to increase immunity levels in Nigeria.
    Jean Baptiste AE; Bawa S; Oteri AJ; Dieng B; Shuaib F; Mulombo WK
    Vaccine; 2021 Nov; 39 Suppl 3():C1-C2. PubMed ID: 34531080
    [No Abstract]   [Full Text] [Related]  

  • 40. Serogroup A meningococcal conjugate (PsA-TT) vaccine coverage and measles vaccine coverage in Burkina Faso--implications for introduction of PsA-TT into the Expanded Programme on Immunization.
    Meyer SA; Kambou JL; Cohn A; Goodson JL; Flannery B; Medah I; Messonnier N; Novak R; Diomande F; Djingarey MH; Clark TA; Yameogo I; Fall A; Wannemuehler K
    Vaccine; 2015 Mar; 33(12):1492-8. PubMed ID: 25636915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.